News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Vertex Receives European Commission Approval for KALYDECO® to Treat Cystic Fibrosis in Infants as Young as 1 Month Old
Saturday, April 27, 2024Vertex Pharmaceuticals has announced today that the European Commission has granted approval for expanding the use of KALYDECO to include infants as young as monthold with cystic fibrosis
Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, Phase 2 Study Assessing Namilumab for Chronic Pulmonary Sarcoidosis
Friday, April 26, 2024Roivant and Kinevant Sciences have recently announced the successful completion of enrollment in their Phase study assessing namilumabs efficacy in treating chronic pulmonary sarcoidosis
Tetra Pharm Technologies and Glysious Announce Partnership to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System
Thursday, April 25, 2024Tetra Pharm Technologies and Glysious are excited to announce a new collaboration aiming to revolutionize transdermal drug delivery systems The partnership intends to enhance several of Tetra
European Commission Approves FILSPARI® (sparsentan) for IgA Nephropathy Treatment, Joint Announcement by CSL Vifor and Travere Therapeutics
Thursday, April 25, 2024CSL Vifor and Travere Therapeutics Inc jointly announced today that FILSPARI has been granted conditional marketing authorization by the European Commission
Multiply Labs and GenScript Biotech Corporation Join Forces to Automate Cell Isolation and Enrichment in Cell Therapy Manufacturing
Wednesday, April 24, 2024GenScript Biotech Corporation and Multiply Labs have teamed up to transform the cell therapy manufacturing process Their partnership focuses on automating the intricate cell isolation phase
AVEROA Applies to European Medicines Agency for Approval of AVA1014 in Treating Complications Linked to Chronic Kidney Disease
Wednesday, April 24, 2024Averoa a biopharmaceutical company focused on innovative therapeutic solutions for renal diseases has announced the submission of a marketing authorization application to the European Medicines
Regeneration Biomedical Initiates First Patient in Phase I Clinical Trial Administering Stem Cell Therapy Directly into Alzheimer’s Patients’ Brains
Wednesday, April 24, 2024Regeneration Biomedical Inc a company focused on developing stem cell therapies for neurodegenerative diseases has reached a significant milestone by dosing the first patient in a Phase
Ochre Biomedicine and Bailingjia Ingelheim Collaborate on Innovative Treatments for Advanced Liver Disease
Tuesday, April 23, 2024Ochre Bio a pioneer in the realm of drug development for chronic liver ailments has forged a partnership with Boehringer Ingelheim a prominent German pharmaceutical company Their joint efforts
Hyundai Bioscience's Preclinical Study Shows Success with Niclosamide-based Oral Anticancer Treatment for Triple-Negative Breast Cancer
Monday, April 22, 2024Hyundai Bioscience has announced positive results from its preclinical study on triplenegative breast cancer The study investigated a combination therapy of a Niclosamidebased oral anticancer drug
Cognivia Secures €15.5 Million in Strategic Funding for AI and ML-Driven Drug Development
Saturday, April 20, 2024Cognivia an innovative AI company revolutionizing pharmaceutical and biotech clinical research with cuttingedge AIML algorithms proudly announces a significant investment milestone Vesalius Biocapital
